ORGS - Orgenesis Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 569.3M
Enterprise Value 3103.35M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.71
Price/Book (mrq)3.34
Enterprise Value/Revenue 35.54
Enterprise Value/EBITDA 6-9.15

Trading Information

Stock Price History

Beta (3Y Monthly) 1.47
52-Week Change 3-41.38%
S&P500 52-Week Change 36.90%
52 Week High 39.2500
52 Week Low 33.7800
50-Day Moving Average 34.2640
200-Day Moving Average 34.7096

Share Statistics

Avg Vol (3 month) 329.34k
Avg Vol (10 day) 323.34k
Shares Outstanding 5N/A
Float 12.32M
% Held by Insiders 126.45%
% Held by Institutions 12.78%
Shares Short (Jun 28, 2019) 4174.91k
Short Ratio (Jun 28, 2019) 44.4
Short % of Float (Jun 28, 2019) 41.32%
Short % of Shares Outstanding (Jun 28, 2019) 41.09%
Shares Short (prior month May 31, 2019) 4123.84k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 212/1
Last Split Date 3Nov 16, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Nov 30, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -98.05%
Operating Margin (ttm)-74.61%

Management Effectiveness

Return on Assets (ttm)-15.09%
Return on Equity (ttm)-54.17%

Income Statement

Revenue (ttm)18.66M
Revenue Per Share (ttm)1.39
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)7.83M
EBITDA -11.29M
Net Income Avi to Common (ttm)-19.18M
Diluted EPS (ttm)-1.4340
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.36M
Total Cash Per Share (mrq)0.89
Total Debt (mrq)17.75M
Total Debt/Equity (mrq)38.88
Current Ratio (mrq)1.77
Book Value Per Share (mrq)1.29

Cash Flow Statement

Operating Cash Flow (ttm)-15.68M
Levered Free Cash Flow (ttm)-17.26M